NEW YORK (GenomeWeb) – Pressure BioSciences today reported its first quarter revenues were up 9 percent year over year despite not recording any grant revenues in the recently completed quarter.

For the three months ended March 31, the South Easton, Mass.-based firm posted $404,147 in revenues, up from $370,737 a year ago. While it had no grant revenues in Q1 2014, compared to $149,168 a year ago, revenues generated from the sales of its products and services and other revenues grew 82 percent to $404,147 from $221,569.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.